Amyloidosis in Alzheimer's disease: The toxicity of amyloid beta (A β), mechanisms of its accumulation and implications of medicinal plants for therapy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Prasansuklab, Anchalee ^a   Tencomnao, Tewin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DONEPEZIL; GALANTAMINE; GLUCOSE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMANTINE; OXYGEN; RIVASTIGMINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTOPHAGY; BRAIN BLOOD FLOW; CHOLINERGIC SYSTEM; CLEARANCE; COMPLEX FORMATION; HUMAN; MICROVASCULATURE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK ASSESSMENT;

EID: 84878703130     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/413808     Document Type: Review

References (116)

1. Alzheimer A., Stelzmann R. A., Schnitzlein H. N., Murtagh F. R., An English translation of Alzheimer's 1907 paper, 'uber eine eigenartige erkankung der hirnrinde'. Clinical Anatomy 1995 8 6 429 431 2-s2.0-0028856460 10.1002/ca.980080612
2. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer's disease. Alzheimer's and Dementia 2007 3 3 186 191 2-s2.0-34249697099 10.1016/j.jalz.2007.04.381 (Pubitemid 46825511)
3. Westermark P., Benson M. D., Buxbaum J. N., Cohen A. S., Frangione B., Ikeda S. I., Masters C. L., Merlini G., Saraiva M. J., Sipe J. D., A primer of amyloid nomenclature. Amyloid 2007 14 3 179 183 2-s2.0-34547913439 10.1080/13506120701460923 (Pubitemid 47262691)
4. Pepys M. B., Amyloidosis. Annual Review of Medicine 2006 57 223 241 2-s2.0-32944457929 10.1146/annurev.med.57.121304.131243 (Pubitemid 43261989)
5. Merlini G., Bellotti V., Molecular mechanisms of amyloidosis. The New England Journal of Medicine 2003 349 6 583 596 2-s2.0-0042709605 10.1056/NEJMra023144 (Pubitemid 36951371)
6. Rambaran R. N., Serpell L. C., Amyloid fibrils: abnormal protein assembly. Prion 2008 2 3 112 117 2-s2.0-65649133114
7. Benson M. D., James S., Scott K., Liepnieks J. J., Kluve-Beckerman B., Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney International 2008 74 2 218 222 2-s2.0-46249120706 10.1038/ki.2008.152 (Pubitemid 351915083)
8. Glenner G. G., Wong C. W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications 1984 120 3 885 890 2-s2.0-0021256895 (Pubitemid 14104991)
9. Mann D. M. A., Alzheimer's disease and Down's syndrome. Histopathology 1988 13 2 125 137 2-s2.0-0023729624
10. Shamas-Ud-Din S., Holmes C., Genetics of down's syndrome and Alzheimer's disease. British Journal of Psychiatry 2002 181 167 168 2-s2.0-0036344395 (Pubitemid 34864506)
11. Thinakaran G., Koo E. H., Amyloid precursor protein trafficking, processing, and function. Journal of Biological Chemistry 2008 283 44 29615 29619 2-s2.0-57649221135 10.1074/jbc.R800019200
12. O'Brien R. J., Wong P. C., Amyloid precursor protein processing and alzheimer's disease. Annual Review of Neuroscience 2011 34 185 204 2-s2.0-79959886270 10.1146/annurev-neuro-061010-113613
13. Storey E., Cappai R., The amyloid precursor protein of Alzheimer's disease and the A β peptide. Neuropathology and Applied Neurobiology 1999 25 2 81 97 2-s2.0-0032902647 10.1046/j.1365-2990.1999.00164.x (Pubitemid 29221758)
14. Kitazume S., Tachida Y., Kato M., Yamaguchi Y., Honda T., Hashimoto Y., Wada Y., Saito T., Iwata N., Saido T., Taniguchi N., Brain endothelial cells produce amyloid β from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form. Journal of Biological Chemistry 2010 285 51 40097 40103 2-s2.0-78650056151 10.1074/jbc.M110.144626
15. Schmitt T. L., Steiner E., Klingler P., Lassmann H., Grubeck-Loebenstein B., Thyroid epithelial cells produce large amounts of the Alzheimer β-amyloid precursor protein (APP) and generate potentially amyloidogenic APP fragments. Journal of Clinical Endocrinology and Metabolism 1995 80 12 3513 3519 2-s2.0-0028876293
16. Fukumoto H., Tomita T., Matsunaga H., Ishibashi Y., Saido T. C., Iwatsubo T., Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid β peptides ending at A β 40 and A β 42. NeuroReport 1999 10 14 2965 2969 2-s2.0-0033615250 (Pubitemid 29507762)
17. Hayes G. M., Howlett D. R., Griffin G. E., Production of β -amyloid by primary human foetal mixed brain cell cultures and its modulation by exogenous soluble β -amyloid. Neuroscience 2002 113 3 641 646 2-s2.0-0037008875 10.1016/S0306-4522(02)00191-4 (Pubitemid 34874687)
18. Koudinov A. R., Koudinova N. V., Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. Journal of the Neurological Sciences 2005 229-230 233 240 2-s2.0-14844321855 10.1016/j.jns.2004.11.036 (Pubitemid 40341588)
19. Selkoe D. J., Clearing the brain's amyloid cobwebs. Neuron 2001 32 2 177 180 2-s2.0-0035950225 10.1016/S0896-6273(01)00475-5 (Pubitemid 33030186)
20. Deane R., Yan S. D., Submamaryan R. K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A. M., Armstrong D. L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B., RAGE mediates amyloid- β peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine 2003 9 7 907 913 2-s2.0-0037703255 10.1038/nm890 (Pubitemid 36889934)
21. Deane R., Bell R. D., Sagare A., Zlokovic B. V., Clearance of amyloid- β peptide across the blood-brain barrier: Implication for therapies in Alzheimer's disease. CNS and Neurological Disorders 2009 8 1 16 30 2-s2.0-65649105035 10.2174/187152709787601867
22. Behl C., Davis J. B., Lesley R., Schubert D., Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994 77 6 817 827 2-s2.0-0028233494 10.1016/0092-8674(94)90131-7 (Pubitemid 24187680)
23. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., Butterfield D. A., A model for β -amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994 91 8 3270 3274 2-s2.0-0028180518
24. Huang X., Atwood C. S., Hartshorn M. A., Multhaup G., Goldstein L. E., Scarpa R. C., Cuajungco M. P., Gray D. N., Lim J., Moir R. D., Tanzi R. E., Bush A. I., The A β peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999 38 24 7609 7616 2-s2.0-0033564690 10.1021/bi990438f (Pubitemid 29289332)
25. Atwood C. S., Obrenovich M. E., Liu T., Chan H., Perry G., Smith M. A., Martins R. N., Amyloid- β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid- β Brain Research Reviews 2003 43 1 1 16 2-s2.0-0141853765 10.1016/S0165-0173(03)00174-7 (Pubitemid 37130077)
26. Miura T., Suzuki K., Kohata N., Takeuchi H., Metal binding modes of Alzheimer's amyloid β -peptide in insoluble aggregates and soluble complexes. Biochemistry 2000 39 23 7024 7031 2-s2.0-0034643831 10.1021/bi0002479 (Pubitemid 30390396)
27. Huang X., Atwood C. S., Moir R. D., Hartshorn M. A., Tanzi R. E., Bush A. I., Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's A β peptides. Journal of Biological Inorganic Chemistry 2004 9 8 954 960 2-s2.0-12144282992 10.1007/s00775-004-0602-8 (Pubitemid 40109902)
28. Drago D., Bolognin S., Zatta P., Role of metal ions in the A β oligomerization in Alzheimer's disease and in other neurological disorders. Current Alzheimer Research 2008 5 6 500 507 2-s2.0-58049209924 10.2174/156720508786898479
29. Basun H., Forssell L. G., Wetterberg L., Winblad B., Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. Journal of Neural Transmission 1991 3 4 231 258 2-s2.0-0026041595
30. Smith M. A., Harris P. L. R., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9866 9868 2-s2.0-0030885482 10.1073/pnas.94.18.9866 (Pubitemid 27408156)
31. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of the Neurological Sciences 1998 158 1 47 52 2-s2.0-0032507975 10.1016/S0022-510X(98)00092-6 (Pubitemid 28277534)
32. Religa D., Strozyk D., Cherny R. A., Volitakis I., Haroutunian V., Winblad B., Naslund J., Bush A. I., Elevated cortical zinc in Alzheimer disease. Neurology 2006 67 1 69 75 2-s2.0-33746800368 10.1212/01.wnl.0000223644.08653.b5 (Pubitemid 44305464)
33. Qi X. L., Xiu J., Shan K. R., Xiao Y., Gu R., Liu R. Y., Guan Z. Z., Oxidative stress induced by beta-amyloid peptide1-42 is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells. Neurochemistry International 2005 46 8 613 621 2-s2.0-18144392979 10.1016/j.neuint.2005.02.007 (Pubitemid 40614864)
34. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R., Butterfield D. A., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology and Medicine 2002 33 4 562 571 2-s2.0-0037101889 10.1016/S0891-5849(02)00914-0 (Pubitemid 34874977)
35. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R., Butterfield D. A., Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α -enolase and heat shock cognate 71. Journal of Neurochemistry 2002 82 6 1524 1532 2-s2.0-0036733145 10.1046/j.1471-4159.2002.01103.x
36. Butterfield D. A., Boyd-Kimball D., Amyloid β -peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathology 2004 14 4 426 432 2-s2.0-8744276616 (Pubitemid 39524972)
37. Tong Y., Zhou W., Fung V., Christensen M. A., Qing H., Sun X., Song W., Oxidative stress potentiates BACE1 gene expression and A β generation. Journal of Neural Transmission 2005 112 3 455 469 2-s2.0-20944444768 10.1007/s00702-004-0255-3 (Pubitemid 40868054)
38. Coma M., Guix F. X., Ill-Raga G., Uribesalgo I., Alameda F., Valverde M. A., Muñoz F. J., Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiology of Aging 2008 29 7 969 980 2-s2.0-43849107919 10.1016/j.neurobiolaging.2007.01.009 (Pubitemid 351697981)
39. Quiroz-Baez R., Rojas E., Arias C., Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α -, β-and γ -secretase expression. Neurochemistry International 2009 55 7 662 670 2-s2.0-69349091132 10.1016/j.neuint.2009.06.012
40. Chapman P. F., White G. L., Jones M. W., Cooper-Blacketer D., Marshall V. J., Irizarry M., Younkin L., Good M. A., Bliss T. V. P., Hyman B. T., Younkin S. G., Hsiao K. K., Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neuroscience 1999 2 3 271 276 2-s2.0-0033360356 10.1038/6374 (Pubitemid 30491299)
41. Spires T. L., Meyer-Luehmann M., Stern E. A., McLean P. J., Skoch J., Nguyen P. T., Bacskai B. J., Hyman B. T., Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. Journal of Neuroscience 2005 25 31 7278 7287 2-s2.0-23444448170 10.1523/JNEUROSCI.1879-05.2005 (Pubitemid 41113944)
42. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., Selkoe D. J., Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002 416 6880 535 539 2-s2.0-0037041426 10.1038/416535a (Pubitemid 34288854)
43. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008 14 8 837 842 2-s2.0-49149124343 10.1038/nm1782
44. Snyder E. M., Nong Y., Almeida C. G., Paul S., Moran T., Choi E. Y., Nairn A. C., Salter M. W., Lombroso P. J., Gouras G. K., Greengard P., Regulation of NMDA receptor trafficking by amyloid- β Nature Neuroscience 2005 8 8 1051 1058 2-s2.0-23044445669 10.1038/nn1503 (Pubitemid 41061516)
45. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., Malinow R., AMPAR removal underlies A β -induced synaptic depression and dendritic spine loss. Neuron 2006 52 5 831 843 2-s2.0-33845411954 10.1016/j.neuron.2006. 10.035 (Pubitemid 44828454)
46. Almeida C. G., Tampellini D., Takahashi R. H., Greengard P., Lin M. T., Snyder E. M., Gouras G. K., Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiology of Disease 2005 20 2 187 198 2-s2.0-26944467176 10.1016/j.nbd.2005.02.008 (Pubitemid 41476246)
47. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M., Almeida O. F. X., Soluble β -amyloid1-40 induces NMDA-Dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses. Journal of Neuroscience 2005 25 48 11061 11070 2-s2.0-30644475475 10.1523/JNEUROSCI.3034-05.2005 (Pubitemid 43089551)
48. Nagele R. G., D'Andrea M. R., Anderson W. J., Wang H. Y., Intracellular accumulation of β -amyloid1-42 in neurons is facilitated by the α 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 2002 110 2 199 211 2-s2.0-0037066072 10.1016/S0306-4522(01)00460-2 (Pubitemid 34214939)
49. Bayer T. A., Wirths O., Intracellular accumulation of amyloid-Beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Frontiers in Aging Neuroscience 2010 2, article 8
50. Pigino G., Morfini G., Atagi Y., Deshpande A., Yu C., Jungbauer L., LaDu M., Busciglio J., Brady S., Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proceedings of the National Academy of Sciences of the United States of America 2009 106 14 5907 5912 2-s2.0-65249161745 10.1073/pnas.0901229106
51. Du H., Guo L., Yan S. S., Synaptic mitochondrial pathology in Alzheimer's disease. Antioxidants & Redox Signaling 2012 16 12 1467 1475
52. Spuch C., Ortolano S., Navarro C., New insights in the amyloid-Beta interaction with mitochondria. Journal of Aging Research 2012 2012 9 324968 10.1155/2012/324968
53. Busciglio J., Lorenzo A., Yeh J., Yankner B. A., β -Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995 14 4 879 888 2-s2.0-0028986916
54. Zheng W. H., Bastianetto S., Mennicken F., Ma W., Kar S., Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 2002 115 1 201 211 2-s2.0-0037110601 10.1016/S0306-4522(02)00404-9 (Pubitemid 35232701)
55. Blurton-Jones M., LaFerla F. M., Pathways by which A β facilitates tau pathology. Current Alzheimer Research 2006 3 5 437 448 2-s2.0-33846047004 10.2174/156720506779025242 (Pubitemid 46066423)
56. Tseng B. P., Green K. N., Chan J. L., Blurton-Jones M., LaFerla F. M., A β inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiology of Aging 2008 29 11 1607 1618 2-s2.0-51449096696 10.1016/j.neurobiolaging.2007.04.014
57. Ghiso J., Frangione B., Amyloidosis and Alzheimer's disease. Advanced Drug Delivery Reviews 2002 54 12 1539 1551 2-s2.0-0037038813 10.1016/S0169-409X(02)00149-7 (Pubitemid 35346828)
58. Weller R. O., Massey A., Newman T. A., Hutchings M., Kuo Y. M., Roher A. E., Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. American Journal of Pathology 1998 153 3 725 733 2-s2.0-0031679480 (Pubitemid 28419027)
59. Hayden M. R., Tyagi S. C., 'A' is for amylin and amyloid in type 2 diabetes mellitus. Journal of the Pancreas 2001 2 4 124 139 2-s2.0-0035411025 (Pubitemid 38963841)
60. Sanchorawala V., Light-chain (AL) amyloidosis: diagnosis and treatment. Clinical Journal of the American Society of Nephrology 2006 1 6 1331 1341 2-s2.0-34548564578 10.2215/CJN.02740806
61. Husby G., Amyloidosis and rheumatoid arthritis. Clinical and Experimental Rheumatology 1985 3 2 173 180 2-s2.0-0021883883 (Pubitemid 15058060)
62. Westermark P., Bergström J., Solomon A., Murphy C., Sletten K., Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003 10 supplement 1 48 54 2-s2.0-0242391991 (Pubitemid 37372567)
63. Ando Y., Nakamura M., Araki S., Transthyretin-related familial amyloidotic polyneuropathy. Archives of Neurology 2005 62 7 1057 1062 2-s2.0-22844447647 10.1001/archneur.62.7.1057 (Pubitemid 41043725)
64. Kyle R. A., Amyloidosis: a convoluted story. British Journal of Haematology 2001 114 3 529 538 2-s2.0-0034796505 10.1046/j.1365-2141.2001.02999. x (Pubitemid 32953629)
65. Argiles A., Mourad G., Axelrud-Cavadore C., Watrin A., Mion C., Cavadore J. C., High-molecular-mass proteins in heamodialysis-associated amyloidosis. Clinical Science 1989 76 5 547 552 2-s2.0-0024594323 (Pubitemid 19116604)
66. Head M. W., Ironside J. W., Review: creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathology and applied neurobiology 2012 38 4 296 310
67. Kaye G. C., Butler M. G., D'Ardenne A. J., Isolated atrial amyloid contains atrial natriuretic peptide: a report of six cases. British Heart Journal 1986 56 4 317 320 2-s2.0-0022512547 (Pubitemid 16025011)
68. Pedersen W. A., Kloczewiak M. A., Blusztajn J. K., Amyloid β -protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 8068 8071 2-s2.0-0029795254 10.1073/pnas.93.15.8068 (Pubitemid 26277166)
69. Ehrenstein G., Galdzicki Z., Lange G. D., The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer's disease. Biophysical Journal 1997 73 3 1276 1280 2-s2.0-0030807627 (Pubitemid 27360717)
70. Ulrich J., Meier-Ruge W., Probst A., Meier E., Ipsen S., Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathologica 1990 80 6 624 628 2-s2.0-0025000725 (Pubitemid 20342503)
71. Moran M. A., Mufson E. J., Gomez-Ramos P., Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathologica 1993 85 4 362 369 2-s2.0-0027514286 (Pubitemid 23100924)
72. Sberna G., Sáez-Valero J., Beyreuther K., Masters C. L., Small D. H., The amyloid β -protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. Journal of Neurochemistry 1997 69 3 1177 1184 2-s2.0-1842375103 (Pubitemid 27364839)
73. Sberna G., Sáez-Valero J., Li Q. X., Czech C., Beyreuther K., Masters C. L., McLean C. A., Small D. H., Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β -amyloid protein precursor of Alzheimer's disease. Journal of Neurochemistry 1998 71 2 723 731 2-s2.0-0031754362 (Pubitemid 28480420)
74. Inestrosa N. C., Alvarez A., Pérez C. A., Moreno R. D., Vicente M., Linker C., Casanueva O. I., Soto C., Garrido J., Acetylcholinesterase accelerates assembly of amyloid- β -peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996 16 4 881 891 2-s2.0-0029863697 10.1016/S0896-6273(00)80108-7 (Pubitemid 26124065)
75. Rees T., Hammond P. I., Soreq H., Younkin S., Brimijoin S., Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiology of Aging 2003 24 6 777 787 2-s2.0-0038618612 10.1016/S0197-4580(02) 00230-0 (Pubitemid 37288853)
76. De Ferrari G. V., Canales M. A., Shin I., Weiner L. M., Silman I., Inestrosa N. C., A structural motif of acetylcholinesterase that promotes amyloid β -peptide fibril formation. Biochemistry 2001 40 35 10447 10457 2-s2.0-0035807054 10.1021/bi0101392 (Pubitemid 32816655)
77. Inestrosa N. C., Alvarez A., Godoy J., Reyes A., De Ferrari G. V., Acetylcholinesterase-amyloid- β -peptide interaction and Wnt signaling involvement in A β neurotoxicity. Acta Neurologica Scandinavica, Supplement 2000 102 176 53 59 2-s2.0-0034488989 (Pubitemid 32156171)
78. Inestrosa N. C., Urra S., Colombres M., Acetylcholinesterase (AChE)-amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway. Current Alzheimer Research 2004 1 4 249 254 2-s2.0-5144224269
79. Inestrosa N. C., Alvarez A., Dinamarca M. C., Pérez-Acle T., Colombres M., Acetylcholinesterase-amyloid- β -peptide interaction: effect of Congo Red and the role of the Wnt pathway. Current Alzheimer Research 2005 2 3 301 306 2-s2.0-22144490779 10.2174/1567205054367928 (Pubitemid 40980188)
80. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M., RAGE and amyloid- β peptide neurotoxicity in Alzheimer's disease. Nature 1996 382 6593 685 691 2-s2.0-0013615899 10.1038/382685a0 (Pubitemid 26282167)
81. Donahue J. E., Flaherty S. L., Johanson C. E., Duncan J. A., Silverberg G. D., Miller M. C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E. G., RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathologica 2006 112 4 405 415 2-s2.0-33749157416 10.1007/s00401-006-0115-3 (Pubitemid 44469161)
82. Kang D. E., Pietrzik C. U., Baum L., Chevallier N., Merriam D. E., Kounnas M. Z., Wagner S. L., Troncoso J. C., Kawas C. H., Katzman R., Koo E. H., Modulation of amyloid β -protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. Journal of Clinical Investigation 2000 106 9 1159 1166 2-s2.0-0033762062
83. Sagare A., Deane R., Bell R. D., Johnson B., Hamm K., Pendu R., Marky A., Lenting P. J., Wu Z., Zarcone T., Goate A., Mayo K., Perlmutter D., Coma M., Zhong Z., Zlokovic B. V., Clearance of amyloid- β by circulating lipoprotein receptors. Nature Medicine 2007 13 9 1029 1031 2-s2.0-34948888151 10.1038/nm1635 (Pubitemid 47517512)
84. Shibata M., Yamada S., Ram Kumar S., Calero M., Bading J., Frangione B., Holtzman D. M., Miller C. A., Strickland D. K., Ghiso J., Zlokovic B. V., Clearance of Alzheimer's amyloid- β 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. Journal of Clinical Investigation 2000 106 12 1489 1499 2-s2.0-0034521392 (Pubitemid 32038587)
85. Fuentealba R. A., Liu Q., Zhang J., Kanekiyo T., Hu X., Lee J. M., Ladu M. J., Bu G., Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal A β 42 uptake and lysosomal trafficking. PLoS ONE 2010 5 7 2-s2.0-77955604553 10.1371/journal.pone.0011884 e11884
86. Zerbinatti C. V., Wozniak D. F., Cirrito J., Cam J. A., Osaka H., Bales K. R., Zhuo M., Paul S. M., Holtzman D. M., Bu G., Increased soluble amyloid- β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Proceedings of the National Academy of Sciences of the United States of America 2004 101 4 1075 1080 2-s2.0-10744231924 10.1073/pnas.0305803101 (Pubitemid 38160586)
87. Zhou F., van Laar T., Huang H., Zhang L., APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells. Protein & Cell 2011 2 5 377 383
88. Nixon R. A., Autophagy, amyloidogenesis and Alzheimer disease. Journal of Cell Science 2007 120 23 4081 4091 2-s2.0-38349046973 10.1242/jcs.019265
89. Hung S. Y., Huang W. P., Liou H. C., Fu W. M., Autophagy protects neuron from A β -induced cytotoxicity. Autophagy 2009 5 4 502 510 2-s2.0-66349120877 10.4161/auto.5.4.8096
90. O'Connor T., Sadleir K. R., Maus E., Velliquette R. A., Zhao J., Cole S. L., Eimer W. A., Hitt B., Bembinster L. A., Lammich S., Lichtenthaler S. F., Hébert S. S., De Strooper B., Haass C., Bennett D. A., Vassar R., Phosphorylation of the translation initiation factor eIF2 α increases BACE1 levels and promotes amyloidogenesis. Neuron 2008 60 6 988 1009 2-s2.0-57649245230 10.1016/j.neuron.2008.10.047
91. Bell R. D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J. W., Guo H., Rubio A., Van Nostrand W., Miano J. M., Zlokovic B. V., SRF and myocardin regulate LRP-mediated amyloid- β clearance in brain vascular cells. Nature Cell Biology 2009 11 2 143 153 2-s2.0-59649110562 10.1038/ncb1819
92. Chow N., Bell R. D., Deane R., Streb J. W., Chen J., Brooks A., Van Nostrand W., Miano J. M., Zlokovic B. V., Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 823 828 2-s2.0-33846471269 10.1073/pnas.0608251104 (Pubitemid 46154695)
93. Winchester J., Dick M. B., Gillen D., Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year. Archives of Gerontology and Geriatrics 2012 56 1 96 103 10.1016/j.archger.2012.06.016
94. Intlekofer K. A., Cotman C. W., Exercise counteracts declining hippocampal function in aging and Alzheimer's disease. Neurobiology of Disease. In press
95. Maesako M., Uemura K., Kubota M., Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. The Journal of Biological Chemistry 2012 287 27 23024 23033
96. Thomas T., Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiology of Aging 2000 21 2 343 348 2-s2.0-0034603412 10.1016/S0197-4580(00)00100-7 (Pubitemid 30387093)
97. Muralidharan P., Ravi Kumar V., Balamurugan G., Protective effect of Morinda citrifolia fruits on β -amyloid (25-35) induced cognitive dysfunction in mice: an experimental and biochemical study. Phytotherapy Research 2010 24 2 252 258 2-s2.0-75849123785 10.1002/ptr.2922
98. Pachauri S. D., Tota S., Khandelwal K., Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study. Journal of Ethnopharmacology 2012 139 1 34 41
99. Xia W., Zeng J. P., Chen L. B., Jiang A. L., Xiang L., Xu J., Cui X., Han E. J., Inhibition of β -amyloid precursor protein gene in SK-N-SH cells by piperlonguminine/dihydropiperlonguminine components separated from Chinese herbal medicine Futokadsura stem. The Chinese Journal of Physiology 2007 50 4 157 163 2-s2.0-38449110488
100. Li W. Z., Wu W. Y., Huang D. K., Protective effects of astragalosides on dexamethasone and Abeta25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats. Food and Chemical Toxicology 2012 50 6 1883 1890
101. Su S. Y., Cheng C. Y., Tsai T. H., Hsieh C. L., Paeonol Protects Memory after Ischemic Stroke via Inhibiting beta-secretase and Apoptosis. Evidence-based complementary and alternative medicine. eCAM 2012 2012 11 932823 10.1155/2012/932823
102. Lee Y. J., Choi D. Y., Han S. B., Inhibitory effect of ethanol extract of magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease via regulating beta-secretase activity. Phytotherapy Research 2012 26 12 1884 1889 10.1002/ptr.4643
103. Huang J. F., Shang L., Liu P., Timosaponin-BII inhibits the up-regulation of BACE1 induced by Ferric Chloride in rat retina. BMC Complementary and Alternative Medicine 2012 12 1 189
104. Wang Y. H., Du G. H., Ginsenoside Rg1 inhibits β -secretase activity in vitro and protects against A β -induced cytotoxicity in PC12 cells. Journal of Asian Natural Products Research 2009 11 7 604 612 2-s2.0-70449674742 10.1080/10286020902843152
105. Jia H., Jiang Y., Ruan Y., Zhang Y., Ma X., Zhang J., Beyreuther K., Tu P., Zhang D., Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid β -protein in cultured cells. Neuroscience Letters 2004 367 1 123 128 2-s2.0-4043151473 10.1016/j.neulet.2004.05.093 (Pubitemid 39078799)
106. Gong K., Chen C., Zhan Y., Chen Y., Huang Z., Li W., Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. The Journal of Biological Chemistry 2012 287 42 35576 35588
107. Yo Y. Y., Shieh G. S., Hsu K. F., Chao-Liang W., Shiau A. L., Licorice and licochalcone-a induce autophagy in lncap prostate cancer cells by suppression of bcl-2 expression and the mtor pathway. Journal of Agricultural and Food Chemistry 2009 57 18 8266 8273 2-s2.0-70349306540 10.1021/jf901054c
108. Liu J., Zhang Y., Qu J., Xu L., Hou K., Zhang J., Qu X., Liu Y., β -Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 2011 11, article 183 2-s2.0-79956202882 10.1186/1471-2407-11-183
109. Yang F., Lim G. P., Begum A. N., Ubeda O. J., Simmons M. R., Ambegaokar S. S., Chen P., Kayed R., Glabe C. G., Frautschy S. A., Cole G. M., Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 2005 280 7 5892 5901 2-s2.0-20044370990 10.1074/jbc.M404751200 (Pubitemid 40280072)
110. Mishra S., Palanivelu K., The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Annals of Indian Academy of Neurology 2008 11 1 13 19 2-s2.0-42249112650 (Pubitemid 351550812)
111. Zhang C., Browne A., Child D., Tanzi R. E., Curcumin decreases amyloid- β peptide levels by attenuating the maturation of amyloid- β precursor protein. Journal of Biological Chemistry 2010 285 37 28472 28480 2-s2.0-77956498654 10.1074/jbc.M110.133520
112. Jia Y. L., Li J., Qin Z. H., Liang Z. Q., Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. Journal of Asian Natural Products Research 2009 11 11 918 928 2-s2.0-77949595310 10.1080/ 10286020903264077
113. Han J., Pan X. Y., Xu Y., Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy 2012 8 5 812 825
114. Kim J. Y., Cho T. J., Woo B. H., Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Archives of Oral Biology 2012 57 8 1018 1025
115. Brimson J. M., Brimson S. J., Brimson C. A., Rakkhitawatthana V., Tencomnao T., Rhinacanthus nasutus extracts prevent glutamate and amyloid-beta neurotoxicity in HT-22 mouse hippocampal cells: possible active compounds include lupeol, stigmasterol and beta-sitosterol. International Journal of Molecular Sciences 2012 13 4 5074 5097
116. Brimson J. M., Tencomnao T., Rhinacanthus nasutus protects cultured neuronal cells against hypoxia induced cell death. Molecules 2011 16 8 6322 6338